RICHMAP
RICHMAP · Stock · NEW YORK STOCK EXCHANGE, INC. ← Markets

LLY · NEW YORK STOCK EXCHANGE, INC.

Eli Lilly and Co

Pharmaceuticals
$1,111.18
▲ 9.10 (0.83%)
Finnhub · 26. 6. 24. 오전 4:13 기준 (실시간~15분 지연)
차트 TradingView

재무 요약

Finnhub /stock/metric · 연간 기준 · 캐시 6h
PER (연간)
50.42
EPS (연간)
22.95
매출/주 (연간)
72.48
총이익률 (연간)
83.04%
영업이익률 (연간)
40.35%
순이익률 (연간)
데이터 없음
ROE
77.78%
배당수익률
0.63%
52주 최고
1,182.73
52주 최저
623.78
시총 (M)
1,037,874 USDM
상장 주식수 (M)
941.74

▸ Finnhub /stock/profile2 · 캐시 24h · 모든 수치 API 원값 (RICHMAP 가공·추정 없음)

관련 뉴스

Finnhub /company-news · 최근 14일 · 캐시 30min
Yahoo · 2026. 6. 24.

Sector Update: Healthcare Stocks Advance in Afternoon Trading

Healthcare stocks rose Tuesday afternoon, with the NYSE Healthcare Index adding 1.4% and the State S

원문 보기 ↗ Yahoo
Yahoo · 2026. 6. 24.

Nvidia Targets a $300 Billion Pharma Market

BioNeMo Agent Toolkit launches with more than 50 adopters including Anthropic, OpenAI, Eli Lilly

원문 보기 ↗ Yahoo
Yahoo · 2026. 6. 24.

How Eli Lilly's CEO Plans to Defeat Pharma's Boom-Bust Cycle

When Dave Ricks became chief executive officer of Eli Lilly & Co. in 2017, he was facing an industry under siege. Americans held drug companies in lower esteem than airlines, law firms and even the fe…

원문 보기 ↗ Yahoo
Yahoo · 2026. 6. 24.

Lilly Drug Access Draws Attention

Report says FDA and Lilly allowed one patient to receive experimental obesity treatment retatrutide.

원문 보기 ↗ Yahoo
SeekingAlpha · 2026. 6. 23.

Healthcare's Quiet Comeback: Innovation, Obesity Drugs And New Opportunities

After lagging expectations during recent market volatility, the healthcare sector is showing signs of strength. TD Asset Management's Jacky He explains what's driving the sector’s rebound.

원문 보기 ↗ SeekingAlpha
Yahoo · 2026. 6. 23.

Eli Lilly vs Viking Therapeutics: Which GLP-1 Stock Is the Better Buy?

The GLP-1 drug market is massive and still growing fast. Investing in a promising growth stock in the space could lead to significant returns.

원문 보기 ↗ Yahoo
Yahoo · 2026. 6. 23.

Daniel M. Skovronsky, MD, PhD, appointed to Illumina's Board of Directors

Illumina, Inc. (NASDAQ: ILMN) today announced the appointment of Daniel M. Skovronsky, MD, PhD, to its Board of Directors, effective June 16, 2026. Dr. Skovronsky brings extensive experience in drug d…

원문 보기 ↗ Yahoo
Yahoo · 2026. 6. 23.

Here is What to Know Beyond Why Eli Lilly and Company (LLY) is a Trending Stock

Recently, Zacks.com users have been paying close attention to Lilly (LLY). This makes it worthwhile to examine what the stock has in store.

원문 보기 ↗ Yahoo
Yahoo · 2026. 6. 23.

ŌURA and LillyDirect to Expand Support for People Using GLP-1 Therapies with New Tools and Savings Options

SAN FRANCISCO & INDIANAPOLIS, June 23, 2026--ŌURA, maker of the world’s most trusted smart ring, Oura Ring, and LillyDirect, Eli Lilly and Company’s digital health platform designed to connect people …

원문 보기 ↗ Yahoo
Yahoo · 2026. 6. 23.

NVIDIA Announces BioNeMo Agent Toolkit — Tools for Agents to Accelerate Scientific Discovery

NVIDIA BioNeMo Agent Toolkit NVIDIA BioNeMo Agent Toolkit provides domain-specific tools and skills for the agentic life sciences era. News Summary: Industry and research leaders including Dassault Sy…

원문 보기 ↗ Yahoo
Yahoo · 2026. 6. 23.

Sangamo Therapeutics Enters Into Asset Sale Agreements with Lilly and Astellas

Sangamo intends to complete asset sale transactions through a voluntary Chapter 11 reorganization, in an effort to maximize business value for all stakeholders Lilly and Astellas to serve as “stalking…

원문 보기 ↗ Yahoo
CNBC · 2026. 6. 23.

Could there be a $10 trillion company? Tech investing star Laffont thinks so

A new regime of trillion-dollar companies is replacing the 'Magnificent Seven.'

원문 보기 ↗ CNBC
⚡ WHAT-IF ARENA · SIMULATION · 가상 · 실제 거래 아님

내 성향 트레이더로 도전

주어는 당신의 성향이지 이 종목이 아닙니다. 객관식 3개로 트레이더를 만들고, 6시간 동안 30분마다 가상 매매하는 걸 관전합니다. 하루 1번, 외부 개입 0.

⚠ 정보 제공 목적 · 투자 추천·자문 아님

본 페이지는 정보 제공 목적의 종목 정보 색인이며, 투자 권유·자문·중개가 아닙니다. RICHMAP은 증권사·금융투자업자가 아닙니다. 시세·재무·뉴스는 외부 데이터 소스(Finnhub 등)의 정보로 실시간성·정확성을 보증하지 않습니다. 모든 수치는 API 원값으로 RICHMAP의 가공·추정이 없으며, 조회 실패 시 "데이터 없음"으로 명시됩니다. 투자 판단과 그 결과 책임은 본인에게 있으며, 실제 거래는 정식 인가 증권사를 통해 본인 판단하에 진행하시기 바랍니다.